View in EDS

Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.

Saved in:
Bibliographic Details
Title: Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.
Authors: Goede V; Department of Oncogeriatrics, St. Marien Hospital, Cologne, Germany., Fischer K; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Giza A; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom., Eckart MJ; Oncology Practice, Erlangen, Germany., Mϋller L; Oncology Practice, Leer, Germany., Smolej L; 4th Department of Internal Medicine - Haematology, Charles University Faculty of Medicine, University Hospital, Hradec Králové, Czech Republic., Kutsch N; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Fink AM; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Hallek M; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.; Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
Source: Blood advances [Blood Adv] 2025 May 27; Vol. 9 (10), pp. 2431-2435.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40101233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goede+V%22">Goede V</searchLink>; Department of Oncogeriatrics, St. Marien Hospital, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Fischer+K%22">Fischer K</searchLink>; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Robrecht+S%22">Robrecht S</searchLink>; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Giza+A%22">Giza A</searchLink>; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Dyer+MJS%22">Dyer MJS</searchLink>; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Eckart+MJ%22">Eckart MJ</searchLink>; Oncology Practice, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Mϋller+L%22">Mϋller L</searchLink>; Oncology Practice, Leer, Germany.<br /><searchLink fieldCode="AU" term="%22Smolej+L%22">Smolej L</searchLink>; 4th Department of Internal Medicine - Haematology, Charles University Faculty of Medicine, University Hospital, Hradec Králové, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kutsch+N%22">Kutsch N</searchLink>; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Fink+AM%22">Fink AM</searchLink>; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Stilgenbauer+S%22">Stilgenbauer S</searchLink>; Department of Internal Medicine III, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Hallek+M%22">Hallek M</searchLink>; Department I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology Cologne, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.; Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 May 27; Vol. 9 (10), pp. 2431-2435.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40101233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2024014875
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2431
    Titles:
      – TitleFull: Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goede V
      – PersonEntity:
          Name:
            NameFull: Fischer K
      – PersonEntity:
          Name:
            NameFull: Robrecht S
      – PersonEntity:
          Name:
            NameFull: Giza A
      – PersonEntity:
          Name:
            NameFull: Dyer MJS
      – PersonEntity:
          Name:
            NameFull: Eckart MJ
      – PersonEntity:
          Name:
            NameFull: Mϋller L
      – PersonEntity:
          Name:
            NameFull: Smolej L
      – PersonEntity:
          Name:
            NameFull: Kutsch N
      – PersonEntity:
          Name:
            NameFull: Fink AM
      – PersonEntity:
          Name:
            NameFull: Stilgenbauer S
      – PersonEntity:
          Name:
            NameFull: Hallek M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 05
              Text: 2025 May 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1